Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
European Urology Oncology(2024)
Key words
Advanced urothelial carcinoma,Antibody-drug conjugate,Enfortumab vedotin,Genomic biomarkers,Tumor mutation burden
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined